Esker Therapeutics, Inc.
Records under this name other than patents Esker Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Esker Therapeutics, Inc.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 11,053,219 | Substituted Pyridines as TYK2 Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 11,731,956 | Substituted 1,2,4-Triazoles as Intermediates in the Syntheisis of TYK2 Inhibitors Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,006,306 | Substituted Pyridazines as TYK2 Inhibitors Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,060,343 | Substituted 1,2,4-Triazoles as Intermediates in the Synthesis of TYK2 Inhibitors Formerly held In force · Low confidence | In force | Low confidence | |
| US 12,351,572 | Substituted 1,2,4-Triazoles as TYK2 Inhibitors Formerly held In force · Low confidence | In force | Low confidence |